Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR

Fig. 2

LAPTM4B is a serum marker in patients with lung adenocarcinoma. a The concentration of LAPTM4B in the serum of patients with LAC and healthy controls. b The changes of LAPTM4B concentration in chemotherapy patients with LAC. c Concentration of LAPTM4B in LAC patients of different chemotherapy efficacy groups. d LAPTM4B concentration in LAC patients with different EGFR-TKIs sensitivity. e Receiver operating characteristic (ROC) curve for LAPTM4B in healthy controls and patients with LAC. *P < 0.05, ***P < 0.001

Back to article page